Stay updated on Intratumoral Cavrotolimod With PD-1 Blockade Clinical Trial

Sign up to get notified when there's something new on the Intratumoral Cavrotolimod With PD-1 Blockade Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Intratumoral Cavrotolimod With PD-1 Blockade Clinical Trial page

  1. Check
    4 days ago
    No Change Detected
  2. Check
    11 days ago
    No Change Detected
  3. Check
    19 days ago
    Change Detected
    Summary
    Added a Locations section listing study sites by state (Arizona, California, Colorado, Florida, Illinois, Iowa, Kentucky, Massachusetts, Missouri, New Hampshire, New Jersey, New York, North Carolina, Ohio, Oregon, Pennsylvania, Texas, Washington, West Virginia) and updated to Revision: v3.3.3; removed the previous separate Arizona Locations, California Locations, etc.
    Difference
    2%
    Check dated 2025-12-23T20:48:13.000Z thumbnail image
  4. Check
    26 days ago
    No Change Detected
  5. Check
    47 days ago
    Change Detected
    Summary
    A Publications section wording change clarifies that PubMed-derived publications are auto-filled and may not all be about the study, and the footer revision indicator shows v3.3.2. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.1%
    Check dated 2025-11-25T10:22:03.000Z thumbnail image
  6. Check
    54 days ago
    Change Detected
    Summary
    The site-wide funding/operating status notice has been removed from the page. The trial details shown on this page remain unchanged.
    Difference
    0.3%
    Check dated 2025-11-18T06:50:12.000Z thumbnail image
  7. Check
    69 days ago
    Change Detected
    Summary
    No additions or deletions detected; the page content remains unchanged with respect to study details, eligibility criteria, and locations.
    Difference
    0.3%
    Check dated 2025-11-03T20:38:16.000Z thumbnail image
  8. Check
    97 days ago
    Change Detected
    Summary
    Updated to v3.2.0 with an operational status notice; removed a specific disease resource (Cutaneous neuroendocrine carcinoma) and v3.1.0 reference.
    Difference
    2%
    Check dated 2025-10-06T04:49:53.000Z thumbnail image
  9. Check
    104 days ago
    Change Detected
    Summary
    Updated version from v3.0.2 to v3.1.0, indicating a new release. No other content changes were detected.
    Difference
    0.0%
    Check dated 2025-09-29T01:31:03.000Z thumbnail image

Stay in the know with updates to Intratumoral Cavrotolimod With PD-1 Blockade Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Intratumoral Cavrotolimod With PD-1 Blockade Clinical Trial page.